References
- Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7:653–660. doi:https://doi.org/10.1038/nrurol.2010.190.
- Kunter U. Urinary tract infections. Nephrologe. 2020;15:119–131. doi:https://doi.org/10.1007/s11560-020-00408-8.
- Baker SJ, Payne DJ, Rappuoli R, et al. Technologies to address antimicrobial resistance. Proc Natl Acad Sci U.S.A. 2018;115:12887–12895. doi:https://doi.org/10.1073/pnas.1717160115.
- Vihta KD, Stoesser N, Llewelyn MJ, et al. Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998–2016: a study of electronic health records. Lancet Infect. Dis. 2018;18:1138–1149. doi:https://doi.org/10.1016/S1473-3099(18)30353-0.
- Flores-Mireles AL, Walker JN, Caparon M, et al. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13:269–284. doi:https://doi.org/10.1038/nrmicro3432.
- Mishra MP, Padhy RN. Antibacterial activity of green silver nanoparticles synthesized from Anogeissus acuminata against multidrug resistant urinary tract infecting bacteria in vitro and host-toxicity testing. J Appl Biomed. 2018;16:120–125. doi:https://doi.org/10.1016/j.jab.2017.11.003.
- Sahoo CR, Paidesetty SK, Padhy RN. Nornostocine congeners as potential anticancer drugs: an overview. Drug Dev Res. 2019;80:878–892. doi:https://doi.org/10.1002/ddr.21577.
- Sahoo CR, Paidesetty SK, Padhy RN. Norharmane as a potential chemical entity for development of anticancer drugs. Eur J Med Chem. 2019;162:752–764. doi:https://doi.org/10.1016/j.ejmech.2018.11.024.
- Sahoo CR, Maharana S, Mandhata CP, et al. Biogenic silver nanoparticle synthesis with cyanobacterium Chroococcus minutus isolated from Baliharachandi sea-mouth, Odisha, and in vitro antibacterial activity. Saudi J Biol Sci. 2020;27:1580–1586. doi:https://doi.org/10.1016/j.sjbs.2020.03.020.
- Padhy RN, Nayak N, Dash-Mohini RR, et al. Growth, metabolism and yield of rice cultivated in soils amended with fly ash and cyanobacteria and metal loads in plant parts. Rice Sci. 2016;23:22–32. doi:https://doi.org/10.1016/j.rsci.2016.01.003.
- Nayak N, Padhy RN, Singh PK. Evaluation of antibacterial and antioxidant efficacy of the fern Azolla caroliniana symbiotic with the Cyanobacterium Anabaena azollae. Proc Natl Acad Sci India Sect B - Biol Sci. 2015;85:555–569. doi:https://doi.org/10.1007/s40011-014-0370-3.
- Najdenski HM, Gigova LG, Iliev II, et al. Antibacterial and antifungal activities of selected microalgae and cyanobacteria. Int J Food Sci Technol. 2013;48:1533–1540. doi:https://doi.org/10.1111/ijfs.12122.
- Vijayakumar S, Menakha M. Pharmaceutical applications of cyanobacteria – a review. J Acute Med. 2015;5:15–23. doi:https://doi.org/10.1016/j.jacme.2015.02.004.
- Kathiraven T, Sundaramanickam A, Shanmugam N, et al. Green synthesis of silver nanoparticles using marine algae Caulerpa racemosa and their antibacterial activity against some human pathogens. Appl Nanosci. 2015;5:499–504. doi:https://doi.org/10.1007/s13204-014-0341-2.
- Mishra MP, Rath S, Swain SS, et al. In vitro antibacterial activity of crude extracts of 9 selected medicinal plants against UTI causing MDR bacteria. J King Saud Univ - Sci. 2017;29:84–95. doi:https://doi.org/10.1016/j.jksus.2015.05.007.
- Baral N, Mohapatra S, Raiguru BP, et al. Microwave-assisted rapid and efficient synthesis of new series of chromene-based 1,2,4-oxadiazole derivatives and evaluation of antibacterial activity with molecular docking investigation. J Heterocycl Chem. 2019;56:552–565. doi:https://doi.org/10.1002/jhet.3430.
- Mishra NP, Mohapatra S, Sahoo CR, et al. Design, one-pot synthesis, molecular docking study, and antibacterial evaluation of novel 2H-chromene based imidazo[1,2-a]pyridine derivatives as potent peptide deformylase inhibitors. J Mol Struct 2021;1246:131183. doi:https://doi.org/10.1016/j.molstruc.2021.131183.
- Sahoo CR, Paidesetty SK, Dehury B, et al. Molecular dynamics and computational study of Mannich-based coumarin derivatives: potent tyrosine kinase inhibitor. J Biomol Struct Dyn. 2020;38:5419–5428. doi:https://doi.org/10.1080/07391102.2019.1701554.
- Sahoo CR, Paidesetty SK, Sarathbabu S, et al. Molecular dynamics simulation, synthesis and topoisomerase inhibitory actions of vanillin derivatives: a systematic computational structural integument. J Biomol Struct Dyn. 2021; 1–11. doi:https://doi.org/10.1080/07391102.2021.1961867
- Lin CS, Chou TL, Wu JT. Biodiversity of soil algae in the farmlands of mid-Taiwan. Bot Stud. 2013;54. doi:https://doi.org/10.1186/1999-3110-54-41.
- Deng Z, Hu Q, Lu F, et al. Colony development and physiological characterization of the edible blue-green alga, Nostoc sphaeroides (Nostocaceae, Cyanophyta). Prog Nat Sci. 2008;18:1475–1483. doi:https://doi.org/10.1016/j.pnsc.2008.03.031.
- Mollenhauer D, Bengtsson R, Lindstrøm EA. Macroscopic cyanobacteria of the genus nostoc: a neglected and endangered constituent of European inland aquatic biodiversity. Eur J Phycol. 1999;34:349–360. doi:https://doi.org/10.1080/09670269910001736412.
- Sand-Jensen K. Ecophysiology of gelatinous Nostoc colonies: unprecedented slow growth and survival in resource-poor and harsh environments. Ann Bot. 2014;114:17–33. doi:https://doi.org/10.1093/aob/mcu085.
- Yue S, Liu J, Zheng R, et al. The growth of Nostoc flagelliforme cells in desert soil and its ecological effects. Adv Mater Res. 2012, 518–523: 5500–5505. doi:https://doi.org/10.4028/www.scientific.net/AMR.518-523.5500.
- Guljamow A, Kreische M, Ishida K, et al. High-density cultivation of terrestrial Nostoc strains leads to reprogramming of secondary metabolome. Appl Environ Microbiol. 2017;83; doi:https://doi.org/10.1128/AEM.01510-17.
- Kumar V, Singh S, Srivastava B, et al. Green synthesis of silver nanoparticles using leaf extract of Holoptelea integrifolia and preliminary investigation of its antioxidant, anti-inflammatory, antidiabetic and antibacterial activities. J Environ Chem Eng. 2019;7; 103094. doi:https://doi.org/10.1016/j.jece.2019.103094.
- Dutta T, Ghosh NN, Das M, et al. Green synthesis of antibacterial and antifungal silver nanoparticles using citrus limetta peel extract: experimental and theoretical studies. J Environ Chem Eng. 2020;8; 4, 104019. doi:https://doi.org/10.1016/j.jece.2020.104019.
- Rohaizad A, Shahabuddin S, Shahid MM, et al. Green synthesis of silver nanoparticles from catharanthus roseus dried bark extract deposited on graphene oxide for effective adsorption of methylene blue dye. J Environ Chem Eng. 2020;8; 4, 103955 doi:https://doi.org/10.1016/j.jece.2020.103955.
- Rao BD. (2015). Antibacterial activity of fresh water Cyanobacteria.
- Bhattacharyya S, Deep R, Nayak B, et al. Antimicrobial activity of two diazotropic cyanobacteria against Staphylococcus aureus. Int J Med Arom Plants. 2013;3:2249–4340. http://www.openaccessscience.com.
- Shaieb FA, Issa AA-S, Meragaa A. Antimicrobial activity of crude extracts of cyanobacteria Nostoc commune and Spirulina platensis, Arch. Biomed Sci. 2014;2:34–41. http://www.journals.tmkarpinski.com/index.php/abms/article/view/221.
- Hamida RS, Abdelmeguid NE, Ali MA, et al. Synthesis of silver nanoparticles using a novel cyanobacteria desertifilum sp. extract: their antibacterial and cytotoxicity effects. Int J Nanomedicine. 2020;15:49–63. doi:https://doi.org/10.2147/IJN.S238575.
- Hamida RS, Ali MA, Goda DA, et al. Cytotoxic effect of green silver nanoparticles against ampicillin-resistantKlebsiella pneumoniae. RSC Adv. 2020;10:21136–21146. doi:https://doi.org/10.1039/d0ra03580g.
- Tan LT. Bioactive natural products from marine cyanobacteria for drug discovery. Phytochemistry. 2007;68:954–979. doi:https://doi.org/10.1016/j.phytochem.2007.01.012.
- Cabanillas AH, Tena Pérez V, Maderuelo Corral S, et al. Cybastacines A and B: antibiotic sesterterpenes from a nostoc sp. cyanobacterium. J Nat Prod. 2018;81:410–413. doi:https://doi.org/10.1021/acs.jnatprod.7b00638.